Julie Anne Eaton

Address:

3290 S Newcombe St, Lakewood, CO 80227

Phone:

(303)6938863

VIN:

WBANF73587CU23015

Make:

BMW

Model:

5 SERIES

Year:

2007

US Patent:

7934603, May 3, 2011

Filed:

May 2, 2005

Appl. No.:

11/120305

Inventors:

Julie S. Eaton - Conifer CO, US
Robert F. Baugh - Parker CO, US
Lisa M. Lim - Mill Creek WA, US
John G. Rivera - Reading PA, US
Victor D. Dolecek - Englewood CO, US

Assignee:

Arteriocyte Medical Systems, Inc. - Cleveland OH

International Classification:

A61M 37/00
B67D 7/70
B04B 3/00
B04B 15/02
C12N 5/071

US Classification:

2103801, 2101981, 210206, 2103601, 210782, 604 401, 604 601, 604 82, 604181, 604190, 494 13, 494 36, 494 43, 435 2, 435372, 422 44, 422 72, 222135, 2221455

Abstract:

The delivery system of the present invention is comprised of at least two chambers which store, individually, an activated blood component and an inactivated blood component. The first chamber comprises an activating agent and a filter which may be one in the same thus allowing the formed clot to be triturated thereby isolating the thrombin from the clot. The second chamber stores the inactivated blood component that when mixed with thrombin will produce a gel. The first or second chamber may further contain agents which are desired to be delivered to a specific site. The unique design of the delivery system allows for ease in operation of combining two agents at a specific time and place.

US Patent:

20020004038, Jan 10, 2002

Filed:

Apr 9, 2001

Appl. No.:

09/832729

Inventors:

Robert Baugh - Parker CO, US
Lisa Lim - Mill Creek WA, US
Julie Eaton - Conifer CO, US
John Rivera - Reading PA, US
Victor Dolecek - Englewood CO, US

International Classification:

A61K045/00
A61M005/00

US Classification:

424/093700, 604/190000

Abstract:

The delivery system of the present invention is comprised of at least two chambers which store, individually, an activated blood component and an inactivated blood component. The first chamber comprises an activating agent and a filter which may be one in the same thus allowing the formed clot to be triturated thereby isolating the thrombin from the clot. The second chamber stores the inactivated blood component that when mixed with thrombin will produce a gel. The first or second chamber may further contain agents which are desired to be delivered to a specific site. The unique design of the delivery system allows for ease in operation of combining two agents at a specific time and place.